<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 76 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page75.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=76">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 76 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 76</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=76"><img src="../thumb/76.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Central Nervous System - 1.8                                                    2020-04 / 45
       (S2) TABS, [P/S] Z/5.7.2/228  Drug interactions: MAOI poss.enhanc. antimuscar. propret.of   N&V/uraem. condits. / malign.dis./GI disord./post-anaesthet. vom-
       792217-004: 50 mg, 20, R24,09  other meds., antimuscar. eff. enhanc.by meds.with antimuscar.pro-  it., speeds up gastr.empty.& dilat. duod.bulb in esp. cases where Ba
       Dosage: Admin. 20-30 mins.prior to depart.for mot. sickn.& may be   pret., absorpt. of other meds.poss.affect.by reduc. gastric motility,   meal studies are delay.by duod. cap spasms/ facilit.exam.of hypoton.
       repeat. 4-6 hrly.if necess.   eff.enhanc.by CNS depress., antimuscarin. & parasympathomimet.  stomach with delay.empty./N&V contr.or prevent. of Ba vomit.occur. in
       Adults & childr.over 12 yrs: 1 tab 3xdly. Childr. 6-12 yrs: ½   poss counteract each other’s effs., antacids/ antidiarrh. poss.reduc.  some pts.undergo.Ba meal examin., aid.gastro-intest. intubat.proced.
       tab 3xdly.                    absorpt., ketoconaz. absorpt. reduc., CNS sedat.effs.enhanc., pyridox.   (S4) TABS, [P/S] L/5.7.2/322.
       (S2) SYRUP, [P/S] X/5.7/5     reduc.levodopa effs.except if dopa decarboxylase inhibit.giv., activ.  714828-017: 10 mg, 500, R198,14
       792225-015: 12,5 mg/5 ml, 50 ml, R24,52  of altretamine reduc., phenobarb.& phenytoin ser.conc.decr., poss.   (S4) SYRUP, [P/S] L/5.7.2/319. 5 mg/5 ml.
       Dosage: Admin.3xdly. Take ½ hr.bef.depart.for mot.sickn.  interacts.with ciclospor./ethionamide/ hydralaz. & immunosuppress.  714844-004: 100 ml, R28,61
       Childr. 6-12 yrs: 10 ml. 1-5 yrs: 5 ml.                    Dosage: Admin.3xdly.
       Contraindications: Porphyr., alcoh.intoxic., pregn., prev.adverse   ASPEN GRANISETRON, Aspen Pharmacare (Pty) Ltd  Adults & childr.over 14 yrs: 10 mg. Childr: 5-14 yrs: 5 mg. 3-5
       reacts.to cyclizine, safety in lactat.not est.  See Section 6.2  yrs: 2,5 mg.
       Side effects: CNS effs., blurr.vis., hypotens., musc. weakn.& inco-  BIO DOMPERIDONE, Biotech [P/S]  (S4) INJ, [P/S] P/5.7.2/53. 10 mg/2 ml.
       ordinat., tinnit., anorex., GI disturbs., diffic.micturit., dry mouth, tight   Domperidone.  714836-001: 10, R60,08
       chest, tingl., heavin.& weakn.of hands, fix.drug erupt., gen.chorea,   Indications: Delay.gastr.empty.of funct.origin with gastro-oesophag.  Dosage: Admin.IV/IM depend.on severity.
       hypersens., hepatit., large dos.poss. precip. convuls.in epilep., allergy   reflux &/dyspeps., N&V of centr./loc.origin/aft.cytostat.& radiat.ther.,   Adults & childr.over 14 yrs: 10 mg 1-3xdly. Childr. 5-14 yrs: 2,5 mg
       incl.anaphylax., bld. dyscras., masks warn.signs of ototox.drug dam-  facilit. upper GIT radiologic.examinat.  2xdly. 3-5 yrs: 1 mg 2xdly. 1-3 yrs: 0,5 mg 2xdly.
       age, may aff.drug metabol.in liv.  (S4) TABS, 42/5.7.2/0836  Diagnost.radiology: IV: 10-20 mg 5-15 mins.bef. IM: 10-20 mg
       Special precautions: Glauc., prostat. hypertrophy.  715830-001: 10 mg, 10, R54,48  10-15 mins.bef.
       Drug interactions: Enhanc.sedat.eff.of CNS depress. incl.alcoh.,   715830-002: 10 mg, 100, R544,81  Contraindications: Concom.phenothiazin., susp./ confirm.phae-
       eff.of atrop.& TCA’s enhanc.  Dosage: Do not exceed max.dly.dos.of 80 mg. Not recomm.for   ochromocyt., pregn.& lactat., intest. obstruct., immed.aft.surg.,
       ADCO-CONTROMET, AI Pharm Ltd [P/S]  childr.weigh.&lt;35 kg    convuls.disords.
                                                                  Side effects: Extrapyramid. sympt., gen.musc. tone incr., Parkinson-
       Metoclopramide mono HCl.      Ac.condits (N&V): Admin.3-4xdly.bef.meals & at bedt. Adults: 20   ism &/tard. dyskines.esp. dur. prolong ther.in elderly, CNS effs., dizzin.,
       Indications: Adjunct.to x-ray exam of stomach & duoden., post-  mg. Childr.over 12 yrs.&gt;35 kgs: 10 mg.  GI disturbs., hyperprolactinaem., trans.plasma aldosterone conc.incr.
       vagot.syndr., anti-emet.      Chron.condits.(main.dyspeps): Admin.bef. meals & at bedt.   Special precautions: Teratogenicit.in animals, excret. in breast
       (S4) TABS, [P/S] K/11.2/49.   Adults: 10 mg 3xdly. If necess. dos.may be doubl.  milk, childr./young pts./elderly, reg. review dur. prolong.ther., signif.
       715875-124: 10 mg, 500, R74,73  Contraindications: Prolactin secret./produc. pituit. tum., where   ren.impairm., fluid retent.risk in hepat.impairm., concom.meds. also
       (S4) SYRUP, [P/S] K/11.2/50. 5 mg/5 ml.  gastr.motil.stimulat.to be avoid., bradycard./heartblock, pre-exist.card.  caus. extrapyramid.reacts., porphyr., tab.cont. lact., syrup cont.sac-
       783064-004: 50 ml, R7,47      dis., family hist./known congenit.long QT interv., comcom. oral keto-  char., inj.sugar free.
       Dosage: Adults: 10 mg 8 hrly.  conazole/itraconazole & other meds. inhibit.hepat.cytochrome en-  Drug interactions: Enhanc.CNS depress.eff., antagonis. eff.with
       Diagn.radiology & duod.intubat: 20 mg bef.Ba meal.  zyme CYP3A4 e.g. macrolid.antibiot./HIV prot.inhib./azole antifung.,   antimuscarin.agents/opioid analges.
       Childr.5-14 yrs: 2,5-5 mg 3xdly. 3-5 yrs: 2 mg 2-3xdly.  safety in pregn.& lactat.not est., childr. und.12 yrs., concom.MAOI’s.
       Contraindications: Pregn., intest.obstruct., immed. post-op., phaeo-  Side effects: Dry mouth, headache, dizzin., irritab., nervousn., thirst,   EMETROL, (Litha) Pharmacare [P/S]
       chromocyt., convuls.          extrapyramid.effs., dyston. reacts., conjunctiv., hot flushes, menstrual   Sucrose 3,77 g, phosphoric acid 85% 0,025 g/5 ml.
       Side effects: Extrapyramid.sympt., Parkinsonism and/or tard.dys-  irregularit., mastalg., revers.rais.ser.prolactin., prurit., rash, urticar.,   Indications: Naus.assoc.with GI disords.
       kines., GI disturbs., CNS effs., galactorrh., gynaecomast., trans.  oed., stomat., asthen., lethargy, urin.freq.change ,dysur., GI dis-  (S0) ORAL SOL. C/5.7.2/968.
       plasma aldoster.conc.incr., hypertens.cris.in pts.with phaechromocyt.  turbs., leg cramps, palpitat., hypertens.crisis with phaeochromocyt.  723037-027: 100 ml, R17,02
       Special precautions: Childr., young pts., elderly, review regul.with   Special precautions: Ren./hepat.impairm., fluid retent.risk, re-  723037-019: 200 ml, R24,50
       prolong.ther., ren./hepat. impairm., fluid retent.risk, tard.dyskines.,   view prolong.ther.reg., poss.neurolog. eff. where bld.brain barrier   Dosage: Adults: 10-20 ml. Childr: 5-10 ml every 15 mins.until naus.
       drugs caus. extrapyramid.reacts., poss.eff.absorpt.of other drugs.  not fully develop./ impair.  subsid. Do not exceed 5 dos./hr.
       Drug interactions: CNS depress.eff.enhanc., anticholinergs.& narcot.   Drug interactions: Incr.macrolide antibiot.plasma conc., lev.incr.  Contraindications: Ren.fail., diabet., heredit. fruct. intol.
       analges.antagon.eff., interfer.with drugs with hypoprolactinaem.eff.  with MAOI/tranylcypromine & moclobemide, eff.poss.antagon.by   Special precautions: Avoid fluids immed.prior/ 15 mins.aft.admin.
                                     antimusc. agents & opioids, absorpt.of other oral med.poss. affect.
       ADCO-CYCLIZINE SYRUP, AI Pharm Ltd [P/S]  partic.sust.rel./enter.coat.formulat., poss. interfer. with other hy-  EMEX, (Cipla Medpro) Mirren [P/S]
       Cyclizine HCl.                poprolactinaem.agents, antacids & antisecret.agents low.the oral   Invert sugar 3 g/5 ml.
       Indications: Prevent.& treatm.of N&V esp. motion sickn., laby-  bioavailabil., absorpt.imp.by reduc.gastr.acidity, periph. eff.of dopa-  Indications: Naus.in motion sickn.& early pregn.
       rinth.disords.                minerg.agon.suppress.        (S0) SYRUP. W/5.7.2/205.
       (S2) SYRUP, 27/5.7/0259. 12,5 mg/5 ml.                     784346-011: 100 ml, R39,89
       808962-019: 50 ml, R25,07     BIO METOCLOPRAMIDE, Biotech [P/S]  784346-003: 200 ml, R59,86
       Dosage: Admin. 3xdly. Childr. 6-12 yrs: 10 ml. 1-5 yrs: 5 ml. Take   Metoclopramide monohydrochloride.  Dosage: Do not dil.
       ½ hr.bef.depart. for mot.sickn.  Indications: Gastr.stasis/hypomotil., naus.in GI disords & drug   Motion sickn. Adults: 15-30 ml bef.start.trip rep.every 15 mins.
       Contraindications: Pregn.     induc.naus.                  unt.sympt.subside. Max.5 dos. Childr.over 3 yrs: 5-10 ml rep.every
       Side effects: Drowsin., dry mouth, blurr.vis., anticholinerg./CNS/  (S4) TABS. V/5.7.2/0352  15 mins. unt.sympt.subside. Max.5 dos.
       psych. effs., dizzin., hypotens., musc.weakn., incoordinat., GI disturbs.,   717891-001: 10 mg, 500, R62,12  Morn.sickn: 15-30 ml taken on arising, repeat.3 hrly.as need.
       headache, tinnit., diffic.micturit., tight chest, tingl., heavin.& weakn.  Dosage: Admin.3xdly.  Contraindications: Methyl alcoh.poison., ren. fail., diabet., heredit.
       of hands, cerebr.stimul.in childr., bld. dyscras., masks warn.signs of   Adults: 1 tab. Childr. 5-14 yrs: ½ tab. Total dly dos.in childr.&   fruct.intol., childr.und.3 yrs. not recomm.
       ototox.drug damage, poss.metab.of drugs in liv.affect., allerg.reacts.   young adults: 0,5 mg/kg/bm.  Special precautions: No fluid prior/15 mins.aft. dose. Do not take
       incl. bronch.asthma, fix.drug erupt., gen.chorea, hypersens. hepatit.  Contraindications: Intest.obstruct., immed.aft. surg., phaeochro-  for more than 1 hr/5 doses without consult.physic.
       Special precautions: Condits.poss.exacerbat. by/ advers.affect.  mocyt., pregn.& lactat.
       by atrop., aspir.sens.        Side effects: Extrapyramid.effs., dyston.reacts., depress., lassit.,   GRANICIP, Cipla Medpro (Pty) Ltd
       Drug interactions: Enhanc.sedat.eff.of CNS depress. incl.alcoh.,   insomn., headache, GI disturbs., tong.& periorbit. oed., skin rash,   See Section 6.2
       eff.of atrop.& TCA’s enhanc.  drowsin., fatig., dizz., restlessn., anx., galactorrh., gynaecomast.,   GRANISETRON FRESENIUS, Fresenius Kabi South Africa
                                     breast engorgem., amenorrh., impot., tard. dyskines. with prolong.ther.
       ADCO-GRANISETRON, Adcock Ingram Critical Care (Pty) Ltd.  Special precautions: Child.& young pts., concom. medicat.with   See Section 6.2
       See Section 6.2               extrapyramid.eff., incr.in mammary neoplasms in rodents aft.chron.  GRANTRYL, Aspen Pharmacare (Pty) Ltd
       ADCO-METOCLOPRAMIDE, (AI Crit.Care) AI Ltd [P/S]  admin., Parkinson.  See Section 6.2
                                     Drug interactions: Eff.antagon.by anti-cholinerg. & narcot. an-
       Metoclopramide HCl            alges., poss.dimin./enhanc.absorpt.of other medic., eff.of CNS   HIDRIST, Aurobindo [P/S]
       Indications: Adjunct to x-ray exam.of stomach & duoden., post   depress.enhanc.  Betahistine dihydrochlor.
       vagot.syndr., anti-emet.                                   Indications: Vertigo assoc.with Ménière’s syndr.
       (S4) INJ, K/11.2/169. 10 mg/2 ml  CLOMAX, (Ascendis) Mediscience [P/S]  (S3) TABS. 45/5.6/0573
       856134-007: 10x2 ml, R34,96.  Metoclopramide HCl           720325-001: 24 mg, 20, R207,50
       Dosage: Admin.IV/IM. Adults: 10 mg 8 hrly.  Indications: Gastr.stasis/hypomotil., naus.in GI disords & drug   Dosage:  Adults: Maint: 24-48 mg dly.in div.dos. One 24 mg tab.
       Diagn.radio.& duoden.intubat: 20 mg bef. exam.  induc.naus.  twice dly. Indiv.accord.to respon.
       Contraindications: Pregn., phenothiazines treatm., psychiatr.pts.  (S4) TABS. 27/5.7.2/0170  Contraindications: Act.pept.ulc., phaeochromocytoma., insuffic.
       Side effects: Constip., drowsin., trans.dyston. usual.aft.large dos.,   700712-002: 10 mg, 500, R72,37  data on use dur.pregn.& lactat.,
       extrapyramidal effs.          Dosage: Admin.3xdly.         Side effects: Hypersens.reacts., headache, GI disturbs., cutan.
       Drug interactions: Act.diminish.by anticholinergs.  Adults: 1 tab. Childr. 5-15 yrs: ½ tab. Total dly dos.in childr.&   hypersens.reacts.
       ASIC, (AI Pharm) Pharmaceut.Enterprises [P/S]  young adults: 0,5 mg/kg/bm.not to be exceed.  Special precautions: Asthma, pept.ulc.hist., avoid concom.antihist.
                                     Contraindications: Intest.obstruct., immed.aft. surg., phaeochro-
       Dicyclomine HCl 10 mg, doxylamine succin.10 mg, pyridox.HCl 50 mg  mocyt., pregn.& lactat.  KYTRIL, Pharmaco Distribution (Pty) Ltd.
       Indications: N&V of pregn.    Side effects: Extrapyramid.effs., dyston.reacts., depress., lassit.,   See Section 6.2
       (S2) TABS, G/5.7/80           insomn., headache, GI disturbs., tong.& periorbit. oed., skin rash,
       705136-019: 30, R72,79.       drowsin., fatig., dizz., restlessn., anx., galactorrh., gynaecomast.,   MEDAZINE NAUSEA TABLETS, Cipla Medpro [P/S]
       Dosage: 2 tabs.at bedt.,1 tab.bef.ris.& mid-aftern. in sev.cases.  breast engorgem., amenorrh., impot., tard. dyskines. with prolong.  Cyclizine HCl.
       Contraindications: Epilep., ac.asthma  ther., incr.plasma aldosterone conc.  Indications: Prevent.& treatm.of N&V & motion sickn., vertigo &
       Side effects: Allerg.reacts., diffic.in talk./ swallow., giddin., drow-  Warnings and special precautions: Childr.& young pts., con-  labyrinth.disords.
       sin., tiredn., headache, stagger., incr.IOP, loss.of vis.accomodat., pho-  com.meds.with extrapyramid.eff., Parkinson., review long-term   (S2) TABS, [P/S] 27/5.7.2/0203.
       tophob., trans.bradycard.follow.by tachycard., orthostat. hypotens.,   treatm.reg.esp.in elderly.  792853-024: 50 mg, 10, R17,44
       flush., reduc.GIT tone & motility, retrostern.pain from incr.gastr.reflux.,   Drug interactions: Eff.antagon.by anti-cholinerg. & narcot. an-  792853-008: 50 mg, 20, R34,87
       bloat. feel., skin dryn., urin.urgen./diffic.& retent., decr.breast milk   alges., poss.dimin./enhanc.absorpt.of other medic., eff.of CNS   Dosage: Adults & childr.over 12 yrs: 1 tab 3xdly. Childr. 6-12
       flow, thirst, anaphylax., abnorm. co-ordinat., convuls., tinnit., oed.,   depress.enhanc.  yrs: ½ tab 3xdly. Admin. 20-30 mins.prior to depart.for mot.sickn.&
       hypotens., pharyngit., tight chest, dry mouth, GI disturbs., cholestat.,   may be repeat. 4-6 hrly.
       hepat., hepat.funct. abnormal., musc.weakn., dysur.  CLOPAMON, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  (S2) SYRUP, [P/S] 27/5.7.2/0204. 12,5 mg/5 ml.
       Warnings and special precautions: Lact./ sucr./ fruct.intol., ad-  Metoclopramide monohydrochlor.  792845-005: 50 ml, R20,48
       min.2 hrs.aft.ketoconazole, warn. signs of ototox.from aminoglycos.  Indications: Condits.assoc.with gastr.stasis/ hypomotil./postva-  Dosage: Admin. 3xdly. Childr. 6-12 yrs: 10 ml. 1-5 yrs: 5 ml. Take
       poss. mask., excret.in breast milk.  got.syndr.managem., anti-emet. agent in N&V contr.in meds.-induc.   ½ hr.bef.depart.for mot.sickn.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page75.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page71.html">71</a>&nbsp;&nbsp;&nbsp;<a href="page72.html">72</a>&nbsp;&nbsp;&nbsp;<a href="page73.html">73</a>&nbsp;&nbsp;&nbsp;<a href="page74.html">74</a>&nbsp;&nbsp;&nbsp;<a href="page75.html">75</a>&nbsp;&nbsp;&nbsp;<a href="page76.html">76</a>&nbsp;&nbsp;&nbsp;<a href="page77.html">77</a>&nbsp;&nbsp;&nbsp;<a href="page78.html">78</a>&nbsp;&nbsp;&nbsp;<a href="page79.html">79</a>&nbsp;&nbsp;&nbsp;<a href="page80.html">80</a>&nbsp;&nbsp;&nbsp;<a href="page81.html">81</a>
             </td>
             <td width="35%"><a href="page77.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page77.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
